Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous oxide for pain during bone marrow biopsy
NCT00219713Phase 3
Key facts
- Status
- Terminated
- Start
- Mar 2000
- Countries
- 1
- Sponsor
- CHU de Poitiers
- Modality
- Small Molecules
- Drugs
- nitrous oxide
- Conditions
- pain
01
Overview
Phase 3, randomised, double-blind trial in pain comparing Nitrous Oxide with Placebo (2 arms). Primary endpoint: Pain intensity during bone marrow biopsy. Started Mar 2000; status: terminated.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Nitrous Oxide
Inhaled 50% nitrous oxide/oxygen mixture + local anesthetic.
Placebo
Inhaled placebo gas + local anesthetic.
03
Endpoints
Primary
Pain intensity during bone marrow biopsy
Secondary
Tolerability
Quality of the picture sample
Beyond the preview
Go deeper on NCT00219713.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219713.